We like to revisit Medical Marijuana, Inc. (OTCMKTS:MJNA) frequently here on Street Register, as a player in cannabis, one of our favorite market spaces for speculative investing and short-term trading alike.
Like many cannabis related plays, MJNA spent the past few weeks under consolidation after an amazing run-up to the 04/20 holiday, which we did predict several times right here on the site. The pullback is to be expected, but its now that we want to re-initiate our interest in these stocks as many of them, MJNA included, are appearing to find support in readiness for what could be a significant rebound.
In the news, Medical Marijuana, Inc. (OTCMKTS:MJNA) today announced that both the Company and its subsidiary Kannaway®, have booked their largest-ever (unaudited) sales revenue in their history in April of 2018, as well as reached major milestones in business operations. Medical Marijuana, Inc. subsidiary HempMeds® had its largest (unaudited) sales revenue month since August of 2014.
“We’re excited to announce that April 2018 was the largest revenue month in the history of our Company,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We’re experiencing tremendous momentum for our entire portfolio of companies and look forward to building upon our success in May.”
Medical Marijuana, Inc. experienced many accomplishments in April 2018 including subsidiary HempMeds® exhibiting at the 2018 World Medical Cannabis Conference and releasing a new Active Relief Roll-On product, its subsidiary Kannaway® hosting its largest national convention in company history and releasing several new products and services, and the Company obtaining positive news coverage in several national and international publications including Men’s Health, GQ, Forbes, HelloGiggles, Nylon and Equinox’s Furthermore Magazine.
“This achievement further demonstrates that Medical Marijuana, Inc. and its subsidiaries will continue to be leaders in the cannabis industry,” said Medical Marijuana, Inc. COO Blake Schroeder. “In addition to staying abreast of cannabis legislation and scientific studies, we’re constantly exploring the needs of our customers and working to continue providing the highest quality products.” (Source: PR Newswire)
In other news, MJNA revealed that NFL legend and former fullback for the Kansas City Chiefs, Christian “Nigerian Nightmare” Okoye, has become a spokesperson for its subsidiary Kannaway® to help spread awareness on the therapeutic benefits of cannabidiol (CBD) for athletes and those looking to lead a healthy, active lifestyle.
“We’re thrilled to work with Mr. Okoye and to continue the conversation about the benefits that athletes like him are experiencing from using CBD,” said Kannaway CEO Blake Schroeder. “His personal story is a perfect example of how CBD not only can improve a person’s life, but also enable them to continue living the active lifestyles they have grown accustomed to.”
As a Kannaway® spokesperson, Okoye regularly uses Kannaway® Pure Gold CBD liquid, Kannaway® Gold Premium Oral Applicator and the Kannaway® Chocolate Energy Chews.
“I’m looking forward to sharing my experience with Kannaway’s many unique CBD products. I was skeptical at first but now I couldn’t imagine life without them,” said Okoye. “I hope my story can help spread awareness of the benefits of CBD so that athletes like me can feel comfortable giving it a try.” (Source: PR Newswire)
In addition to sales reaching their highest levels in company history, we find a partnership with someone so well-known and loved in the athletic community, should be highly beneficial to MJNA, as Christian Okoye is a household name among football fans everywhere. We’ll stay up on any further developments with MJNA and pass them along to you!. Keep it locked on Street Register for updates, and we’ll deliver important developments on MJNA as they unfold. In the meantime, if you’ve yet to sign up for our 100% free newsletter, do so now! Just enter your active email address into the box below and submit!
Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in MJNA stock, short or long.